Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

41
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
41
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

61
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
61
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

79
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
79
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

938
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
938

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic and clinical insights into the coexistence of multiple myeloma and diffuse large B cell lymphoma from a case report and systematic review with bioinformatics analysis.

Discover oncology·2026
Same author

In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer.

Cancer biomarkers : section A of Disease markers·2026
Same author

Paraneoplastic Pemphigus Mimicking Stevens-Johnson Syndrome in a Patient with Multiple Myeloma: A Rare and Clinically Challenging Presentation.

International journal of hematology-oncology and stem cell research·2026
Same author

Intermittent Theta Burst Stimulation Mitigates Depressive-Like behavior in Rats Subjected to Maternal Separation.

Basic and clinical neuroscience·2026
Same author

Intraoperative complications during gender-affirming laparoscopic hysterectomy in transgender men receiving testosterone: a case series.

BMC surgery·2026
Same author

Promising Therapeutic Potential of miR-220-3p Mimic Against Murine Trimethyltin Hippocampal Injury.

Iranian journal of pharmaceutical research : IJPR·2026
Same journal

Anti-inflammation and Anti-insulin Resistance of a Compound from Vietnamese <i>Clerodendrum chinense</i> Leaves.

Iranian journal of pharmaceutical research : IJPR·2026
Same journal

Pharmacological SIRT2 Inhibition by AGK2 Attenuates Hapten-Induced Keratinocyte Inflammation via NF-κB/NLRP3 Suppression and Nrf2 Reactivation.

Iranian journal of pharmaceutical research : IJPR·2026
Same journal

Baicalein Protects H9c2 Cardiomyoblasts Against LPS-Induced Inflammatory Injury by Modulating the NF-κB/NLRP3 Inflammasome Pathway and Mitochondrial ROS.

Iranian journal of pharmaceutical research : IJPR·2026
Same journal

Quercetin Induces Macrophage Polarization through PI3K-AKT Pathway in Atherosclerosis: Network Pharmacology, Molecule Docking and in vitro Analysis.

Iranian journal of pharmaceutical research : IJPR·2026
Same journal

Four Steroidal Saponins Isolated from the Aerial Parts of <i>Allium jesdianum</i> Exhibit Antibiofilm Effects Against Colistin-Resistant Clinical Strains, with an In Silico Study.

Iranian journal of pharmaceutical research : IJPR·2026
Same journal

Photodynamic Therapy Combined with Gemcitabine for Prostate Cancer Using Nanoprobe for in-vivo CEST Imaging.

Iranian journal of pharmaceutical research : IJPR·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.3K

Time-Dependent Molecular Changes Following MDMA-Induced Nephrotoxicity.

Mehrdad Roghani1, Ravieh Golchoobian2,3, Maryam Mohammadian4

  • 1Neurophysiology Research Center, Shahed University, Tehran, Iran.

Iranian Journal of Pharmaceutical Research : IJPR
|January 20, 2025
PubMed
Summary
This summary is machine-generated.

Recreational ecstasy (MDMA) use can harm kidneys. This study found MDMA reduced kidney TNF-α and TGF-β, suggesting cytokine pathway disruption may underlie its renal adverse effects.

Keywords:
3,4-MethylenedioxymethamphetamineAcute Kidney InjuryApoptosisEcstasyInflammation

More Related Videos

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.1K
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Related Experiment Videos

Last Updated: Jun 1, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

8.3K
Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
15:43

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

18.1K
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
09:02

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion

Published on: February 2, 2021

4.4K

Area of Science:

  • Nephrology
  • Toxicology
  • Molecular Biology

Background:

  • Recreational 3,4-methylenedioxymethamphetamine (MDMA) use is rising, with documented cases of fatal renal failure.
  • MDMA's renal toxicity mechanisms are not fully understood, potentially involving direct tissue damage or systemic effects.

Purpose of the Study:

  • To investigate the renal effects of a single MDMA dose in rats.
  • To explore the molecular mechanisms, including cytokine and apoptosis pathways, involved in MDMA-induced nephrotoxicity.

Main Methods:

  • Rats received a single intraperitoneal dose of MDMA (20 mg/kg).
  • Renal function was assessed via serum BUN and creatinine.
  • Kidney tissue analysis included TNF-α, TGF-β protein levels (ELISA), Bax, Bcl-xl, Bcl-2 mRNA expression (RT-PCR), apoptosis assays, and histopathology.

Main Results:

  • MDMA administration caused a transient increase in serum BUN and creatinine.
  • Kidney tissue showed decreased TNF-α and TGF-β protein levels.
  • Significant downregulation of pro-apoptotic Bax and anti-apoptotic Bcl-xl mRNA was observed; Bcl-2 expression and apoptosis remained unchanged. No histopathological damage was noted.

Conclusions:

  • MDMA's renal adverse effects may involve the disruption of cytokine signaling pathways.
  • Reduced TGF-β levels, potentially linked to decreased TNF-α, might contribute to MDMA-induced nephrotoxicity.
  • Further research is needed to elucidate the precise mechanisms and long-term consequences.